Author: Xiaolin Yuan; Wanrong Yi; Baoyi Liu; Simiao Tian; Fang Cao; Ruoyu Wang; Baiwen Qi; Faqiang Lu; Meiyun Fang; Fuyang Pei; Ming Chen; Lichuan Zhang; Yong Zhang; Xiuzhi Zhang; Zhenyu Pan; Dewei Zhao; Aixi Yu
Title: Pulmonary radiological change of COVID-19 patients with 99mTc-MDP treatment Document date: 2020_4_14
ID: gzao2fo6_12
Snippet: Besides, there were no serious adverse events including body immunity during the clinical use of 99m Tc-MDP. Additional potential advantage for application of 99m Tc-MDP is to avoid excessive use of glucocorticoids in the treatment of severe COVID-19 patients, in order to prevent further incidence of some glucocorticoids caused complications such as osteonecrosis of femoral head. 4 Limited by the small sample size, larger and longer trials are wa.....
Document: Besides, there were no serious adverse events including body immunity during the clinical use of 99m Tc-MDP. Additional potential advantage for application of 99m Tc-MDP is to avoid excessive use of glucocorticoids in the treatment of severe COVID-19 patients, in order to prevent further incidence of some glucocorticoids caused complications such as osteonecrosis of femoral head. 4 Limited by the small sample size, larger and longer trials are warranted to determine the efficacy of 99m Tc-MDP in the treatment of COVID-19.
Search related documents:
Co phrase search for related documents- adverse event and severe patient: 1, 2, 3, 4, 5, 6, 7
- adverse event and small sample size: 1, 2, 3, 4, 5, 6, 7, 8, 9
- femoral head and sample size: 1
- potential advantage and sample size: 1
- sample size and severe patient: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- sample size and severe patient treatment: 1
- sample size and small sample size: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- severe patient and small sample size: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date